Neurogenesis deficits in Down syndrome: testing recovery with GABA alpha 5 negative allosteric modulator, beta 2 adrenergic agonist and IGF-1 in Ts65Dn mice.

C Albac; F Stagni; Mariagrazia GRILLI; ME Salvalai; R Bartesaghi; MC Potier

Neurogenesis deficits in Down syndrome: testing recovery with GABA alpha 5 negative allosteric modulator, beta 2 adrenergic agonist and IGF-1 in Ts65Dn mice.

C Albac
, F Stagni
, Mariagrazia GRILLI
, ME Salvalai
, R Bartesaghi
, MC Potier

Dipartimento di Scienze del Farmaco

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Lingua originale	Inglese
pagine (da-a)	S445-S446
Rivista	European Neuropsychopharmacology
Volume	29
Stato di pubblicazione	Pubblicato - 1 gen 2019

Altri file e collegamenti

handle

Cita questo

@article{52b2521319c24094b2b4e34b4a3d3ee3,

title = "Neurogenesis deficits in Down syndrome: testing recovery with GABA alpha 5 negative allosteric modulator, beta 2 adrenergic agonist and IGF-1 in Ts65Dn mice.",

author = "C Albac and F Stagni and Mariagrazia GRILLI and ME Salvalai and R Bartesaghi and MC Potier",

year = "2019",

month = jan,

day = "1",

language = "English",

volume = "29",

pages = "S445--S446",

journal = "European Neuropsychopharmacology",

issn = "0924-977X",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Neurogenesis deficits in Down syndrome: testing recovery with GABA alpha 5 negative allosteric modulator, beta 2 adrenergic agonist and IGF-1 in Ts65Dn mice.

AU - Albac, C

AU - Stagni, F

AU - GRILLI, Mariagrazia

AU - Salvalai, ME

AU - Bartesaghi, R

AU - Potier, MC

PY - 2019/1/1

Y1 - 2019/1/1

UR - https://iris.uniupo.it/handle/11579/104708

M3 - Article

SN - 0924-977X

VL - 29

SP - S445-S446

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

ER -